IDiyas

For the Inventor, By the Inventor

Los Angeles, CA, United States of America

Ming Yan

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Los Angeles, CA (US) (2016 - 2022)
  • Encino, CA (US) (2017 - 2023)

Company Filing History:

goldMedal8 out of 15,458 
 
University of California
 patents
silverMedal3 out of 5 
 
Csl Behring Gene Therapy, Inc.
 patents
bronzeMedal3 out of 4 
 
Csl Gene Therapy Pty Ltd.
 patents
4. 1 out of 3 
 
Calimmune, Inc.
 patents
5. 1 out of 2 
 
Calimmune Australia Pty Ltd
 patents
where one patent can have more than one assignee

Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 11795461 - Compositions and methods for treating beta-hemoglobinopathies (2023-10-24),
2. 11253483 - Protease assisted native-protein delivery approach (PANDA) (2022-02-22),
3. 11213548 - Modulatable switch for selection of donor modified cells (2022-01-04),
4. 10961537 - Compositions and methods for treating beta-hemoglobinopathies (2021-03-30),
5. 10568844 - RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules (2020-02-25),
6. 10434069 - Protease assisted native-protein delivery approach (PANDA) (2019-10-08),
7. 10426798 - Modulatable switch for selection of donor modified cells (2019-10-01),
8. 10179112 - Viral vector nanocapsule for targeting gene therapy and its preparation (2019-01-15),
9. 10016490 - Multiple-enzyme nanocomplexes (2018-07-10),
10. 9782357 - RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules (2017-10-10),
11. 9289504 - Single protein nanocapsules for protein delivery with long-term effect (2016-03-22),
12. 9283194 - Methods for protease assisted protein delivery (2016-03-15),
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…